Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?
Riccardo M. Inciardi, Marianna Adamo, Laura Lupi, Marco Metra
Abstract
This commentary refers to'Should atrial fibrillation be considered acardiovascular risk factor for aworse prognosisin COVID-19 patients?', by F. Sanchis-Gomar et al., 2020:41:3092-3093.
Topics & Concepts
MedicineBystander effectAtrial fibrillationCoronavirus disease 2019 (COVID-19)CardiologyInternal medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyImmunologyDiseaseInfectious disease (medical specialty)OutbreakAtrial Fibrillation Management and OutcomesCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19